Skip to the main content.
About Us

BMES serves as the lead society and professional home for biomedical engineers and bioengineers. BMES membership has grown to over 6,700 members, with more than 115+ BMES Student Chapters, five Special Interest Groups (SIGs), and four professional journals.

BMES Hub

Welcome to the BMES Hub, a cutting-edge collaborative platform created to connect members, foster innovation, and facilitate conversations within the biomedical engineering community.

BMES Hub

1 min read

2025 Pritzker Award

2025 Pritzker Award
2:14

Pritzker Distinguished Lecture: Mice, or Microfluidics? Humanizing Biomedical Research with “NAMs”

The 2025 Robert A. Pritzker Distinguished Lecture at the BMES Annual Meeting will be delivered by Dr. Linda Griffith of MIT, a trailblazer in biomedical engineering and women’s health research. Her lecture, titled “Mice, or Microfluidics? Humanizing Biomedical Research with ‘NAMs’,” will explore how the field can move beyond traditional animal models toward more representative, human-focused systems.

Research and development in chronic inflammatory diseases—conditions that disproportionately affect women—remain constrained by reliance on poorly representative animal models. The gaps between animal and human biology, particularly in immunology, hinder progress in identifying mechanisms and validating therapies.

Dr. Griffith’s talk will spotlight two powerful technological developments now converging to address these gaps:

  • Systems biology and immunology analysis of patients, providing deep insights into human immune responses.

  • Microphysiological systems (“organs on chips”), often called living patient avatars, which replicate human tissue function with unprecedented precision.

These innovations are collectively recognized by the NIH as “Novel Approach Methods” (NAMs). The agency has launched the Complement-ARIE (Complement Animal Research In Experimentation) program to accelerate the development and deployment of these approaches.

Gynecology offers a compelling proving ground for NAMs. In her lecture, Dr. Griffith will illustrate how conditions such as endometriosis—where steroid hormone regulation is central to physiology—provide critical case studies for testing and validating new technologies. These efforts have the potential to set benchmarks that ripple across all areas of biomedical research.

The Pritzker Lecture will challenge attendees to rethink research frameworks, champion new standards of evidence, and embrace technologies that more faithfully represent human biology.

Don’t miss this plenary session at the BMES 2025 Annual Meeting in San Diego, October 9, from 11:00AM - 12:15PM.

Call for BMES Committee Members & Medical Devices SIG Members Is Now Open

Call for BMES Committee Members & Medical Devices SIG Members Is Now Open

BMES is now accepting applications for members interested in serving on a BMES Committee and/or as a member of the Medical Devices Special Interest...

Read More
Applications Now Open: Childcare Endowment for Young Investigators Attending the 2026 BMES Annual Meeting

Applications Now Open: Childcare Endowment for Young Investigators Attending the 2026 BMES Annual Meeting

BMES is pleased to announce that applications are now open for the Linda Griffith & Douglas Lauffenburger Endowment, a childcare support initiative...

Read More
BMES Comments on OMB’s Proposed Revisions to Guidance for Federal Financial Assistance

BMES Comments on OMB’s Proposed Revisions to Guidance for Federal Financial Assistance

On July 9, 2026, the Executive Committee of the BMES Board of Directors, sent the following Comment to the Office of Management and Budget, which has...

Read More
Gordana Vunjak-Novakovic Opens BMES Annual Meeting

1 min read

Gordana Vunjak-Novakovic Opens BMES Annual Meeting

This is the fifth in a series of articles highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024 Annual...

Read More
Special Delivery: Using Nanotechnology to Target Cancer

1 min read

Special Delivery: Using Nanotechnology to Target Cancer

This is the fourth in a series of articles highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024...

Read More